3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
21
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Gastrointestinal
1
Classical hematology
1
CNS
1
Conditions
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Herpes Simplex
1
Hemophilia A
1
Hemangioma, Capillary
1
Heart Failure
1
Heart Arrest
1
Interventions
Rivaroxaban
8
Surveys and Questionnaires
7
Heparin, Low-Molecular-Weight
5
apixaban
4
fludarabine
3
Blood Specimen Collection
3
pegfilgrastim
2
epoetin beta
2
Therapeutics
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Observation
2
Microarray Analysis
2
Melphalan
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Flow Cytometry
2
Epoetin Alfa
2
Data Collection
2
Dabigatran
2
Biopsy
2
ziprasidone
1
ribociclib
1
ravulizumab
1
palbociclib
1
oprelvekin
1
iron isomaltoside 1000
1
fludarabine phosphate
1
edoxaban
1
calcium heparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Methylprednisolone
×
Classical hematology
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled